» Articles » PMID: 12924649

Risk Factors for Dysplasia in Patients with Barrett's Esophagus (BE): Results from a Multicenter Consortium

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2003 Aug 20
PMID 12924649
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Studies show Barrett's esophagus prevalence increases with age, while mean length of Barrett's esophagus is unchanged. Few data are available about the relationship between age and length on the development of dysplasia. Our aim was to assess age and length as risk factors for dysplasia. Consecutive patients with Barrett's esophagus were enrolled in a multicenter study establishing a tissue bank of Barrett's esophagus patients 1994 and 1998. Demographics, length of Barrett's esophagus (centimeters), and histology were recorded. Risk factors for dysplasia were assessed, including patient age, gender, and length of Barrett's esophagus. Statistical analysis was performed comparing prevalence of dysplasia (which included the presence of any carcinoma and high- or low-grade dysplasia) to age and length. In all, 309 patients were studied [278 (90%) male and 31 (10%) female]: 5 had adenocarcinoma of the esophagus, 11 had high-grade dysplasia, and 29 had low-grade dysplasia. Patients with Barrett's esophagus without dysplasia were younger than those with dysplasia [62 +/- 0.8 years vs 67 +/- 1.7 years (mean +/- SEM, P = 0.02)]. The risk of dysplasia increased by 3.3%/yr of age. Mean length of Barrett's esophagus in patients with Barrett's alone vs dysplasia was 4.0 +/- 0.2 cm vs 5.4 +/- 0.4 cm (P = 0.003). Patients with Barrett's esophagus length > or = 3 cm had a significantly greater prevalence of dysplasia compared to length < 3 cm (23% vs 9%, P = 0.0001). The risk of dysplasia increased by 14%/cm of increased length. Multivariate analysis showed age and length to be independent risk factors. In conclusions: prevalence of dysplasia is strongly associated with age and length of Barrett's esophagus. These preliminary results can be used to develop a strategy for screening/surveillance based on age and length of Barrett's epithelium.

Citing Articles

A Pilot Study on Automatic Three-Dimensional Quantification of Barrett's Esophagus for Risk Stratification and Therapy Monitoring.

Ali S, Bailey A, Ash S, Haghighat M, Leedham S, Lu X Gastroenterology. 2021; 161(3):865-878.e8.

PMID: 34116029 PMC: 7617121. DOI: 10.1053/j.gastro.2021.05.059.


Multinational survey on the preferred approach to management of Barrett's esophagus in the Asia-Pacific region.

Sen Kew G, Soh A, Lee Y, Gotoda T, Li Y, Zhang Y World J Gastrointest Oncol. 2021; 13(4):279-294.

PMID: 33889279 PMC: 8040063. DOI: 10.4251/wjgo.v13.i4.279.


Predictors of dysplastic and neoplastic progression of Barrett’s esophagus.

Alnasser S, Agnihotram R, Martel M, Mayrand S, Franco E, Ferri L Can J Surg. 2019; 62(2):93-99.

PMID: 30907564 PMC: 6440887. DOI: 10.1503/cjs.008716.


Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.

Schlottmann F, Molena D, Patti M Updates Surg. 2018; 70(3):339-342.

PMID: 30039277 DOI: 10.1007/s13304-018-0564-y.


Histology of Barrett's Metaplasia: Do Goblet Cells Matter?.

Odze R Dig Dis Sci. 2018; 63(8):2042-2051.

PMID: 29998421 DOI: 10.1007/s10620-018-5151-z.


References
1.
van der Veen A, Dees J, Blankensteijn J, van Blankenstein M . Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut. 1989; 30(1):14-8. PMC: 1378223. DOI: 10.1136/gut.30.1.14. View

2.
Reid B, Weinstein W, Lewin K, Haggitt R, Vandeventer G, Denbesten L . Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology. 1988; 94(1):81-90. DOI: 10.1016/0016-5085(88)90613-0. View

3.
Hirota W, Loughney T, Lazas D, Maydonovitch C, Rholl V, Wong R . Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology. 1999; 116(2):277-85. DOI: 10.1016/s0016-5085(99)70123-x. View

4.
Rudolph R, Vaughan T, Storer B, Haggitt R, Rabinovitch P, Levine D . Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med. 2000; 132(8):612-20. DOI: 10.7326/0003-4819-132-8-200004180-00003. View

5.
Cameron A, Lomboy C . Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology. 1992; 103(4):1241-5. DOI: 10.1016/0016-5085(92)91510-b. View